Rogers selected as scholar in emerging leadership program
Cynthia E. Rogers, MD, the Blanche F. Ittleson Professor of Psychiatry at the School of Medicine, has been named an Emerging Leader in Health and Medicine Scholar by the National Academy of Medicine.
Emenecker wins prize for innovation in biomedical science
Ryan Emenecker, a postdoctoral researcher at Washington University School of Medicine, has won the 2022 Regeneron Prize for Creative Innovation.
New practical method of producing Airy beams could enhance ultrasound
Researchers led by the McKelvey School of Engineering’s Hong Chen recently invented a technique for generating ultrasound waves that can self-bend, like a rainbow.
World’s first nasal COVID-19 vaccine approved in India; based on Washington University technology
The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.
Restoring movement after spinal cord injury focus of new research
Ismael Seáñez received a five-year $1 million grant from the National Institutes of Health (NIH) to lead interdisciplinary spinal cord injury research.
Low testosterone may increase risk of COVID-19 hospitalization for men
Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.
Water-based gel to be tested as dressing for diabetic wounds
Jianjun Guan at the McKelvey School of Engineering was awarded a four-year $1.8 million grant from the National Institutes of Health (NIH) to develop a new dressing for chronic wounds in people with diabetes.
Simple blood test predicts neurotoxic complications of CAR-T cell therapy
A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.
Faculty receive $6.1M NIH grant for maternal health study
Three faculty from the Brown School and School of Medicine at Washington University in St. Louis have received a seven-year $6.1 million grant from the National Institutes of Health (NIH) for a project aimed at improving the health of mothers and children in the St. Louis region.
Drug combo therapy in mice blocks drug resistance, halts tumor growth
An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis and colleagues.
View More Stories